SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Trading Update

30 Apr 2024 07:00

RNS Number : 4786M
Rotork PLC
30 April 2024
Β 

Rotork Plc

Trading update

Q1 performance as expected; good visibility into H2

30 April 2024

Rotork plc ("Rotork"), the global provider of mission-critical intelligent flow control solutions, issues the following trading update covering the first quarter period from 1 January to 29 March 2024 ahead of its Annual General Meeting to be held later today.

Trading update

Order intake was good, up low single digits (on an OCC1 basis) against a strong comparative which benefitted from higher levels of project activity.

All divisions achieved higher orders year-on-year (OCC). Book-to-bill was solidly above one, returning to the more typical levels experienced in first quarter periods before the supply chain issues resulting from Covid.

Revenues in the three months grew mid-teens year-on-year (OCC), reflecting the strength of the opening order book and an improved supply chain performance. Oil & Gas and Water & Power sales were well ahead whilst Chemical, Process & Industrial sales were modestly lower. Revenue growth was driven by the Europe, Middle East & Africa and Asia Pacific regions.

The period saw a solid cash performance and the commencement of the Β£50m share buyback announced on 5 March 2024 at 2023 full year results. Net cash at 29 March 2024 was Β£148.6m (December 2023: Β£134.4m).

Outlook

The outlook for our end markets remains positive and our order book gives us good visibility into the second half of the year. Our full year expectations are unchanged and we continue to anticipate 2024 to be another year of progress on an OCC basis.

Rotork will publish 2024 half-year results on Tuesday 6 August 2024.

Β 

ΒΉOCC is organic constant currency results restated at 2023 exchange rates

Β 

Enquiries:

Β 

Rotork plc

Tel: +44 (0)1225 733 200

Kiet Huynh, Chief Executive Officer

Ben Peacock, Chief Financial Officer

Andrew Carter, Investor Relations Director

FTI Consulting

Tel: + 44 (0)20 3727 1340

Nick Hasell / Susanne Yule

Β 

Β 

Legal Entity Identifier: 213800AH5RZIHGWRJ718

Β 

About Rotork

Rotork is a market-leading global provider of mission-critical intelligent flow control solutions for oil & gas, water and wastewater, power, chemical process and industrial applications. We help customers around the world to improve efficiency, reduce emissions, minimise their environmental impact and assure safety. Rotork employs about 3,200 people, has manufacturing facilities in more than 16 locations and serves 170 countries through a global service network. Its shares have a premium listing on the London Stock Exchange (symbol: ROR) and are a constituent of the FTSE 250 index. For more information please visit www.rotork.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFLFVRSLIAFIS
Date   Source Headline
1st Mar 20243:00 pmRNSTotal Voting Rights
1st Mar 20247:00 amRNSDirectorate Change
13th Feb 20243:30 pmRNSDirector/PDMR Shareholding
1st Feb 202411:00 amRNSTotal Voting Rights
11th Jan 20243:30 pmRNSDirector/PDMR Shareholding
2nd Jan 202411:00 amRNSTotal Voting Rights
20th Dec 20235:17 pmRNSDirector Declaration
13th Dec 20233:30 pmRNSDirector/PDMR Shareholding
13th Dec 202311:00 amRNSDirector Declaration
11th Dec 20233:30 pmRNSDirector/PDMR Shareholding
1st Dec 20233:30 pmRNSTotal Voting Rights
22nd Nov 20237:00 amRNSTrading Update
13th Nov 20233:30 pmRNSDirector/PDMR Shareholding
1st Nov 20233:00 pmRNSTotal Voting Rights
11th Oct 20233:30 pmRNSDirector/PDMR Shareholding
9th Oct 20233:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:00 pmRNSTotal Voting Rights
13th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSDirectorate Change – CFO Transition
7th Sep 202311:45 amRNSDirectorate Change
4th Sep 20234:03 pmRNSTotal Voting Rights
14th Aug 20234:30 pmRNSDirector/PDMR Shareholding
8th Aug 20237:00 amRNS2023 Interim Results
1st Aug 20234:36 pmRNSTotal Voting Rights
11th Jul 20233:00 pmRNSDirector/PDMR Shareholding
3rd Jul 202311:30 amRNSTotal Voting Rights
29th Jun 202310:45 amRNSDirectorate Change
19th Jun 202311:00 amRNSDirector Declaration
14th Jun 20233:30 pmRNSHolding(s) in Company
13th Jun 20231:00 pmRNSDirector/PDMR Shareholding
8th Jun 202312:26 pmRNSTotal Voting Rights
15th May 20234:15 pmRNSDirector/PDMR Shareholding
2nd May 20233:15 pmRNSTotal Voting Rights
28th Apr 20233:45 pmRNSDirector/PDMR Shareholding
28th Apr 20233:22 pmRNSResult of AGM
28th Apr 20237:00 amRNSTrading Update
12th Apr 20233:00 pmRNSDirector/PDMR Shareholding
6th Apr 20234:45 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:00 pmRNSTotal Voting Rights
29th Mar 20232:30 pmRNSDirector/PDMR Shareholding
27th Mar 20236:21 pmRNSDirector/PDMR Shareholding
24th Mar 20233:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20234:46 pmRNS2022 Annual Report and Notice of 2023 AGM
15th Mar 20234:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
13th Mar 20233:30 pmRNSDirector/PDMR Shareholding
7th Mar 202311:00 amRNSDirector/PDMR Shareholding
1st Mar 20233:00 pmRNSTotal Voting Rights
28th Feb 20237:00 amRNS2022 Preliminary Results
13th Feb 20233:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.